Table 3.
Biological parameters at allocation.
| Mean ± σ | All groups (n = 113) | BMI (kg/m2) | p value of BMI effect | ||
|---|---|---|---|---|---|
| ≤25 (n = 57) | 25–30 (n = 38) | >30 (n = 18) | |||
| Glucose (mmol/l) | 5.2 ± 0.6 | 5.1 ± 0. 4 | 5.2 ± 0.6 | 5.6 ± 0.8 | 0.25 |
| HDL-cholesterol (mmol/l) | 2.13 ± 1.28 | 2.35 ± 1.35 | 1.98 ± 1.25 | 1.70 ± 0.97 | 0.0001 |
| Transthyretin (g/l) | 0.26 ± 0.04 | 0.26 ± 0.04 | 0.26 ± 0.04 | 0.26 ± 0.04 | 0.88 |
| C-reactive protein (mg/l) | 2.5 ± 3. 6 | 1.3 ± 1.2 | 3.2 ± 4.4 | 5.2 ± 4.9 | 0.000002 |
| Insulin (mUI/l) | 6.5 ± 6.2 | 4.7 ± 4.4 | 6.4 ± 4.4 | 12.1 ± 9.8 | 0.000013 |
| IGF-1 (μg/l) | 96.4 ± 49.3 | 95.8 ± 45.6 | 103.5 ± 45.7 | 84.7 ± 62.6 | 0.23 |
| Leptin (μg/l) | 5.7 ± 4.7 | 3.5 ± 2.6 | 6.0 ± 3.0 | 12.1 ± 6.0 | <10−7 |
| Adiponectin (mg/l) | 8.1 ± 5.1 | 8.9 ± 5.3 | 7.6 ± 4.8 | 6.6 ± 4.4 | 0.072 |
| Leptin/adiponectin ratio | 1.22 ± 2.02 | 0.53 ± 0.51 | 1.26 ± 1.28 | 3.23 ± 3.86 | <10−7 |
| Testosterone (nmol/l) | 0.82 ± 0.36 | 0.79 ± 0.29 | 0.83 ± 0.42 | 0.87 ± 0.38 | 0.67 |
| CA 15-3 (kU/l) | 18.1 ± 18.7 | 20.1 ± 24.5 | 14.1 ± 9.0 | 19.7 ± 8.4 | 0.014 |
Plasma biological parameters are expressed in usual unit per liter. Comparison of outcomes per BMI group at allocation was tested with one-way analysis of variance (ANOVA). The test was two-sided, and the nominal level of significance was 5%.